Asia Pacific Medical Technology Association

Directions Website

Asia Pacific Medical Technology Association Asia Pacific Medical Technology Association (APACMed)

APACMed was established to provide a unifying voice for the medical devices, equipment and in-vitro diagnostics industry in Asia Pacific. We are the first and only regional medical technology association that is headquartered in Asia, solely focused on matters of interest in Asia and the Pacific. Guided by the principles of Access, Innovation and Collaboration, we work with governments, regulators, payers, healthcare providers and others to shape policies that give patients timely access to quality healthcare in both developed and developing markets. Our aim is also to connect and foster collaboration between all actors within the medtech ecosystem, from academics to healthcare practitioners, from startup incubators, to service providers. Our members reflect the diversity of today’s medical technology – from pacemakers to contact lenses, to rapid test kits and high volume disposable devices, to large imaging equipment such as CT’s and MRI’s.

'𝗛𝗲𝗮𝗹𝘁𝗵𝘆 𝗕𝗲𝗴𝗶𝗻𝗻𝗶𝗻𝗴𝘀, 𝗛𝗼𝗽𝗲𝗳𝘂𝗹 𝗙𝘂𝘁𝘂𝗿𝗲𝘀' – this World Health Day, we recognise the power of early health interventions in s...
07/04/2025

'𝗛𝗲𝗮𝗹𝘁𝗵𝘆 𝗕𝗲𝗴𝗶𝗻𝗻𝗶𝗻𝗴𝘀, 𝗛𝗼𝗽𝗲𝗳𝘂𝗹 𝗙𝘂𝘁𝘂𝗿𝗲𝘀' – this World Health Day, we recognise the power of early health interventions in shaping a brighter tomorrow. APACMed remains dedicated to driving innovation and collaboration to ensure equitable healthcare for all.

📊 Here’s a look at APACMed’s impact in 2024—our key milestones, achievements, and growth, all in one snapshot. Swipe thr...
13/02/2025

📊 Here’s a look at APACMed’s impact in 2024—our key milestones, achievements, and growth, all in one snapshot. Swipe through to see how we’re shaping the future of health tech in APAC!

𝗟𝗼𝗰𝗮𝗹𝗶𝘀𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗖𝗵𝗶𝗻𝗮: 𝗡𝗲𝘄 𝗚𝗼𝘃𝗲𝗿𝗻𝗺𝗲𝗻𝘁 𝗚𝘂𝗶𝗱𝗮𝗻𝗰𝗲 𝗮𝗻𝗱 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗖𝗼𝗻𝘀𝘂𝗹𝘁𝗮𝘁𝗶𝗼𝗻In December, China released the draft 𝘕𝘢𝘵𝘪𝘰𝘯𝘢𝘭 𝘗...
06/02/2025

𝗟𝗼𝗰𝗮𝗹𝗶𝘀𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗖𝗵𝗶𝗻𝗮: 𝗡𝗲𝘄 𝗚𝗼𝘃𝗲𝗿𝗻𝗺𝗲𝗻𝘁 𝗚𝘂𝗶𝗱𝗮𝗻𝗰𝗲 𝗮𝗻𝗱 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗖𝗼𝗻𝘀𝘂𝗹𝘁𝗮𝘁𝗶𝗼𝗻
In December, China released the draft 𝘕𝘢𝘵𝘪𝘰𝘯𝘢𝘭 𝘗𝘳𝘰𝘥𝘶𝘤𝘵 𝘚𝘵𝘢𝘯𝘥𝘢𝘳𝘥𝘴 𝘢𝘯𝘥 𝘐𝘮𝘱𝘭𝘦𝘮𝘦𝘯𝘵𝘢𝘵𝘪𝘰𝘯 𝘗𝘰𝘭𝘪𝘤𝘪𝘦𝘴 𝘪𝘯 𝘵𝘩𝘦 𝘍𝘪𝘦𝘭𝘥 𝘰𝘧 𝘎𝘰𝘷𝘦𝘳𝘯𝘮𝘦𝘯𝘵 𝘗𝘳𝘰𝘤𝘶𝘳𝘦𝘮𝘦𝘯𝘵 for public comment, offering key insights into evolving standards and policies.

How will these changes impact the MedTech industry? Join 𝗔𝗣𝗔𝗖𝗠𝗲𝗱 𝗖𝗵𝗶𝗻𝗮 on 𝟮𝟬 𝗙𝗲𝗯𝗿𝘂𝗮𝗿𝘆 for an exclusive webinar to explore:
- Key challenges and opportunities for MedTech
- Sustainable pathways for industry growth
- Actionable recommendations for future policy-making

𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗡𝗼𝘄: https://us02web.zoom.us/webinar/register/WN_xAo3pVzyRkyXyjgF5jki0w #/registration

𝗪𝗵𝗮𝘁'𝘀 𝗡𝗲𝘅𝘁 𝗳𝗼𝗿 𝗠𝗲𝗱𝗧𝗲𝗰𝗵 𝗶𝗻 𝗮 𝘄𝗼𝗿𝗹𝗱 𝗼𝗳 𝗧𝗿𝘂𝗺𝗽 𝟮.𝟬? Day 1 in office. This morning, in sunny Singapore, an expert panel expl...
22/01/2025

𝗪𝗵𝗮𝘁'𝘀 𝗡𝗲𝘅𝘁 𝗳𝗼𝗿 𝗠𝗲𝗱𝗧𝗲𝗰𝗵 𝗶𝗻 𝗮 𝘄𝗼𝗿𝗹𝗱 𝗼𝗳 𝗧𝗿𝘂𝗺𝗽 𝟮.𝟬?
Day 1 in office. This morning, in sunny Singapore, an expert panel explored how Donald Trump’s second term could reshape global trade dynamics and its impact on the MedTech industry in Asia Pacific.

Notably, Dräger's Thomas Jakob shared how companies can position themselves to manage risks and capitalise on gains in a Trump 2.0 era:

1. Continue diversifying your supply chains and explore new markets. Consider building a "China+2" strategy to further future-proof your business.

2. Peel your eyes open for opportunities to become more competitive, such as through portfolio expansion.

3. Be agile. Surprises will come along the way but be prepared to react quickly. Challenges can shape us to be nimble and on our feet.

We are grateful for valuable insights shared by our speakers:
Thomas Jakob, Chief Operating Officer APAC, Managing Director ASEAN, Dräger
Thomas Shao 邵枫, Head, China Government Affairs, Abbott
Prashant Yadav, Senior Fellow for Global Health, Council on Foreign Relations
Benish Aslam, Lead, Government Affairs and Policy & ESG, APACMed
Clark Jennings, Managing Director Asia, Crowell Global Advisors (Moderator)

𝙇𝙞𝙫𝙚 𝙉𝙤𝙬: 𝘼𝙋𝘼𝘾𝙈𝙚𝙙 𝘽𝙧𝙚𝙖𝙠𝙛𝙖𝙨𝙩 𝘾𝙤𝙣𝙫𝙚𝙧𝙨𝙖𝙩𝙞𝙤𝙣𝙨Post US-Elections, What's Next for MedTech?Our panellists are diving into how t...
22/01/2025

𝙇𝙞𝙫𝙚 𝙉𝙤𝙬: 𝘼𝙋𝘼𝘾𝙈𝙚𝙙 𝘽𝙧𝙚𝙖𝙠𝙛𝙖𝙨𝙩 𝘾𝙤𝙣𝙫𝙚𝙧𝙨𝙖𝙩𝙞𝙤𝙣𝙨
Post US-Elections, What's Next for MedTech?
Our panellists are diving into how the US-China relationship is shaping the MedTech sector. What opportunities and challenges will Donald Trump's second term bring? How can organisations de-risk and stay agile in this evolving landscape?
We’re discussing these and more during the session—don’t miss out!
If you’ve RSVP’d for our webinar, join us now!

Thomas Jakob, Dräger | Thomas Shao 邵枫, Abbott | Prashant Yadav, Council on Foreign Relations | Benish Aslam, APACMed | Clark Jennings, Crowell Global Advisors

𝗣𝗼𝘀𝘁-𝗨𝗦 𝗘𝗹𝗲𝗰𝘁𝗶𝗼𝗻𝘀, 𝗪𝗵𝗮𝘁'𝘀 𝗡𝗲𝘅𝘁 𝗳𝗼𝗿 𝗠𝗲𝗱𝗧𝗲𝗰𝗵?As Donald Trump gets sworn in today for his second term as US President, the ...
20/01/2025

𝗣𝗼𝘀𝘁-𝗨𝗦 𝗘𝗹𝗲𝗰𝘁𝗶𝗼𝗻𝘀, 𝗪𝗵𝗮𝘁'𝘀 𝗡𝗲𝘅𝘁 𝗳𝗼𝗿 𝗠𝗲𝗱𝗧𝗲𝗰𝗵?
As Donald Trump gets sworn in today for his second term as US President, the world is bracing for potential shifts in trade policies and economic priorities.
What is the impact on MedTech pricing, market access, and investments in cutting-edge technologies?
What challenges and opportunities might retaliatory trade policies present for companies in the region?

𝗧𝗵𝗶𝘀 𝗪𝗲𝗱𝗻𝗲𝘀𝗱𝗮𝘆 𝗺𝗼𝗿𝗻𝗶𝗻𝗴, join us to uncover actionable strategies from thought leaders that will position your organisation for resilience and success.

Featured Speakers:
Thomas Jakob, Chief Operating Officer APAC, Managing Director ASEAN, Dräger
Thomas Shao, Head, China Government Affairs, Abbott
Prashant Yadav, Senior Fellow for Global Health, Council on Foreign Relations
Benish Aslam, Lead, Government Affairs and Policy & ESG, APACMed
Clark Jennings, Managing Director Asia, Crowell Global Advisors (Moderator)

𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗡𝗼𝘄: https://us02web.zoom.us/webinar/register/WN_eH8j0m8_SIGGKtXDIou_Wg #/registration

𝗣𝗼𝘀𝘁-𝗨𝗦 𝗘𝗹𝗲𝗰𝘁𝗶𝗼𝗻𝘀, 𝗪𝗵𝗮𝘁'𝘀 𝗡𝗲𝘅𝘁 𝗳𝗼𝗿 𝗠𝗲𝗱𝗧𝗲𝗰𝗵?As Donald Trump begins his second term as President of the U.S., global trade...
13/01/2025

𝗣𝗼𝘀𝘁-𝗨𝗦 𝗘𝗹𝗲𝗰𝘁𝗶𝗼𝗻𝘀, 𝗪𝗵𝗮𝘁'𝘀 𝗡𝗲𝘅𝘁 𝗳𝗼𝗿 𝗠𝗲𝗱𝗧𝗲𝗰𝗵?
As Donald Trump begins his second term as President of the U.S., global trade dynamics are set to undergo significant shifts. How will this impact businesses in the Asia Pacific region, and what are the implications for the MedTech sector?

Join us for the first 𝘼𝙋𝘼𝘾𝙈𝙚𝙙 𝘽𝙧𝙚𝙖𝙠𝙛𝙖𝙨𝙩 𝘾𝙤𝙣𝙫𝙚𝙧𝙨𝙖𝙩𝙞𝙤𝙣𝙨 session of 2025, where we will explore how MedTech firms can navigate this evolving environment, turning potential risks into strategic advantages and positioning themselves for long-term success.

Featured Speakers:
Thomas Jakob, Chief Operating Officer APAC, Managing Director ASEAN, Dräger
Prashant Yadav, Senior Fellow for Global Health, Council on Foreign Relations
Benish Aslam, Lead for Government Affairs and Policy & ESG, APACMed
Clark Jennings, Managing Director Asia, Crowell Global Advisors (Moderator)

𝗥𝗲𝗴𝗶𝘀𝘁𝗲𝗿 𝗡𝗼𝘄: https://us02web.zoom.us/webinar/register/WN_eH8j0m8_SIGGKtXDIou_Wg #/registration

25/11/2024

How can all stakeholders work together to build an AI talent ecosystem for MedTech?

This was one of the many critical questions addressed by our panelists in the discussion titled “Future Proofing with AI Talent” at the Asia Pacific MedTech Forum 2024.

The panel comprising of John Eng of EDB, John Collings of Stryker (and Chairman of APACMed Board of Directors), Vy Tran of Siemens Healthineers (and APACMed Board Sponsor for AI) was moderated by Vikram Kapur of Bain & Company.

Key points covered include:

1. Essential skills for the Medtech workforce of tomorrow
2. The talent landscape across APAC and Singapore's role
3. Cultural transformations needed for innovation
4. The importance of AI leadership development

APACMed, together with EDB and Bain & Company, recently launched a white paper on AI Talent here [INSERT URL], and will hold a webinar this Friday - register here to join the conversation [INSERT ZOOM LINK].

Missed the session? Explore our forum highlights here: https://apacmed.org/medtech-forum-2024-highlights/

𝘕𝘰𝘵𝘦: 𝘍𝘶𝘭𝘭 𝘴𝘦𝘴𝘴𝘪𝘰𝘯 𝘳𝘦𝘤𝘰𝘳𝘥𝘪𝘯𝘨𝘴 𝘢𝘳𝘦 𝘢𝘷𝘢𝘪𝘭𝘢𝘣𝘭𝘦 𝘦𝘹𝘤𝘭𝘶𝘴𝘪𝘷𝘦𝘭𝘺 𝘵𝘰 𝘧𝘰𝘳𝘶𝘮 𝘢𝘵𝘵𝘦𝘯𝘥𝘦𝘦𝘴.

21/11/2024

𝗖𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝘃𝗲 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀 𝗳𝗼𝗿 𝗔𝗣𝗔𝗖
Expert insights gathered through roundtables and interviews reveal exciting possibilities: integrating NGS into cancer care not only improves patient outcomes but also generates broader societal and economic benefits. This positions NGS as a vital tool in tackling APAC's rising cancer burden.

To translate this potential into reality, collaboration is key. We encourage all healthcare ecosystem stakeholders to collaborate and enable NGS access across a broader spectrum of cancer patients and cancer types.

Embracing what’s next for cancer care can save lives. Join us in advocating for change and ensure patients across APAC benefit from NGS-driven cancer care.

Read our white paper: https://apacmed.org/advancing-patient-access-to-next-generation-sequencing-for-cancer-in-apac/
Join the NGS Working Group: Contact Binderiya Makhbal and Anirudh Sen



Address

2 Science Park Drive, Ascent Tower A #02-07, Science Park I
Singapore
118222

Opening Hours

Monday 09:00 - 18:00
Tuesday 09:00 - 18:00
Wednesday 09:00 - 18:00
Thursday 09:00 - 18:00
Friday 09:00 - 18:00

Website

Alerts

Be the first to know and let us send you an email when Asia Pacific Medical Technology Association posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category